TINA CRABTREE: Open Payments
NPI 1881935476 · MIDWEST CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 45 payments from 10 companies in 2025. Trend: 2023 $524 · 2024 $432 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| ABBVIE INC. | 8 | $164 |
| Lilly USA, LLC | 8 | $150 |
| Novo Nordisk Inc | 7 | $147 |
| Abbott Laboratories | 4 | $74 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Exact Sciences Corporation | 1 | $16 |
Products named: AIRSUPRA, MOUNJARO, QULIPTA, Ozempic, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, UBRELVY, Saxenda.
Industry payments across OK — which companies pay providers there.
